LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
Illinois IL
Legislatures
2023-2024 Regular Session
House
Bills
HB3957
IL
Illinois House Bill HB3957
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Illinois 2023-2024 Regular Session
Illinois House Bill HB3957
Introduced
2/17/23
Introduced
2/17/23
Refer
2/28/23
Refer
2/17/23
Report Pass
3/8/23
Refer
2/28/23
Refer
3/27/23
Report Pass
3/8/23
Engrossed
5/3/23
Refer
3/27/23
Refer
5/4/23
Engrossed
5/3/23
Refer
5/9/23
Refer
5/4/23
Refer
5/9/23
Report Pass
5/16/23
Report Pass
5/16/23
Enrolled
5/19/23
Enrolled
5/19/23
Chaptered
7/28/23
Chaptered
7/28/23
Passed
7/28/23
Caption
GENERIC DRUG PRICING FAIRNESS
Latest IL HB3957 Activity
View All Events: IL 2023-2024 Regular Session HB3957
Companion Bills
No companion bills found.
Previously Filed As
IL A1646
Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.
IL A3245
Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.
IL S323
Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.
IL A3621
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
IL A2240
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
IL S1667
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
IL HB2558
Essential drugs; price increases; limits
IL HB3256
AFFORDABLE DRUG MANUFACTURING
IL HB2757
Essential drugs; price increases; limits
IL SB1402
Essential drugs; price increases; limits.
Similar Bills
NJ A3621
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
NJ S1667
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
NJ A2240
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
AZ HB2089
Essential drugs; price increase; limits
AZ HB2112
Essential drugs; price increases; limits
AZ HB2757
Essential drugs; price increases; limits
AZ SB1402
Essential drugs; price increases; limits.
AZ HB2558
Essential drugs; price increases; limits